|
|
Logo
Logo Logo

Category Archives: "News"

  1. Home
  2. INforMS
  3. Page 43
Dec 01, 2015
Exploring new paths for the treatment of multiple sclerosis
INforMS
(Edmonton) Research from the University of Alberta's Faculty of Medicine & Dentistry is trailblazing a potential new pathway for the [...]
Elizabeth Porco
Read More
...16
0
Oct 26, 2015
CMSC issues position statement on Aaccess to medications to treat symptoms of multiple sclerosis
CMSC PR
Consortium of Multiple Sclerosis Centers Issues Position Statement on Access to Medications to Treat Symptoms of MS (Hackensack, NJ, [...]
Elizabeth Porco
Read More
...17
0
Oct 21, 2015
Biogen reports top-line results from phase 3 study evaluating Natalizumab in SPMS
INforMS, Partners
Wednesday, October 21, 2015 7:31 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Phase 3 ASCEND study investigating natalizumab in the [...]
Elizabeth Porco
Read More
...16
0
Oct 12, 2015
EMD Serono announces publication of PRISMS-15 year follow-up study using Rebif in RRMS
INforMS, Partners
Rockland, Massachusetts, October 12, 2015 – EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today [...]
Elizabeth Porco
Read More
...16
0
Oct 08, 2015
Treatment effects maintained over 5 years in patients with RRMS who received Lemtrada
INforMS, Partners
Thursday, October 8, 2015 1:00 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, aSanofi company, today announced positive new [...]
Elizabeth Porco
Read More
...14
0
Oct 08, 2015
Genentech’s Ocrelizumab show positive pivotal study results in both RRMS and PPMS
INforMS, Partners
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive [...]
Elizabeth Porco
Read More
...17
0
Oct 08, 2015
EMD Serono announces recipients of the third annual €1 million grant for multiple sclerosis innovation
INforMS, Partners
EMD Serono Announces Recipients of the Third Annual €1 Million Grant for Multiple Sclerosis Innovation Four research grants awarded [...]
Elizabeth Porco
Read More
...15
0
Oct 08, 2015
Results from ZINBRYTA phase 3 DECIDE study presented at ECTRIMS
INforMS
Results from ZINBRYTA™ (Daclizumab High-Yield Process) Phase 3 DECIDE Study Highlighting Efficacy Compared to Interferon Beta-1a [...]
Elizabeth Porco
Read More
...15
0
Oct 07, 2015
New analysis suggests Aubagio slows brain atrophy in people with Relapsing MS
INforMS, Partners
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis Additional MRI data on [...]
Elizabeth Porco
Read More
...15
0
Oct 07, 2015
Data show effects of TECFIDERA in newly-diagnosed and early disease course multiple sclerosis patients
INforMS, Partners
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis [...]
Elizabeth Porco
Read More
...16
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last